CNO (NYSE: CNO) Rule 144 filing covers sale of 9283 shares at 395438.75

Rhea-AI Filing Summary

CNO common stock is the subject of a planned Rule 144 sale of 9283 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of 395438.75. The shares are listed on the NYSE, and 95353512 shares of this class were outstanding, with the approximate sale date noted as 12/15/2025.

The seller acquired 3232 performance shares from the issuer on 02/11/2025 and 6051 restricted shares from the issuer on 03/25/2025, with the nature of payment listed as Not Applicable for both awards. The notice also states that the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9283	395438.75	95353512	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2025	Performance Shares	ISSUER			3232	02/11/2025	Not Applicable
Common	03/25/2025	Restricted Stock	ISSUER			6051	03/25/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Rule 144 notice for CNO disclose?

The notice shows a planned sale of 9283 shares of CNO common stock under Rule 144, with an aggregate market value of 395438.75, to be sold on the NYSE.

How many CNO shares are planned to be sold and what is their market value?

The Rule 144 notice covers the planned sale of 9283 common shares of CNO with an aggregate market value of 395438.75.

When and how were the CNO shares to be sold under Rule 144 acquired?

The notice lists 3232 performance shares acquired from the issuer on 02/11/2025 and 6051 restricted shares acquired from the issuer on 03/25/2025, with the nature of payment shown as Not Applicable for both.

Which broker and exchange are involved in the planned CNO share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are listed for trading on the NYSE.

How many CNO common shares are outstanding according to this Rule 144 notice?

The notice reports that there are 95353512 shares of CNO common stock outstanding.

What representation does the seller make about material information regarding CNO?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.